Document Detail

Echocardiography to individualize treatment for hypertrophic cardiomyopathy.
MedLine Citation:
PMID:  22687587     Owner:  NLM     Status:  MEDLINE    
Treatments for hypertrophic cardiomyopathy are largely selected based on patient symptoms and echocardiographic findings. Moreover, all the advanced treatments for heart failure symptoms depend on such imaging for planning and monitoring response to therapy. Risk of sudden death correlates with maximum left ventricular (LV) wall thickness. Massive LV thickening of 30 mm or more is an indication for primary prevention of sudden death with an implanted defibrillator. In this review, we will underscore potential pitfalls in echocardiographic diagnosis. Also we will review, a newly appreciated pathophysiologic mechanism in obstruction dynamic systolic dysfunction due to gradient.
Mark V Sherrid; Milla Arabadjian
Related Documents :
3336987 - Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs.
21985167 - Therapeutic potential of ginseng in the management of cardiovascular disorders.
7127357 - Extension of myocardial necrosis into normal epicardium followng hypotension during exp...
22396777 - M3 subtype of muscarinic acetylcholine receptor promotes cardioprotection via the suppr...
3351467 - Cardiac injury during valve replacement surgery.
17394957 - Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes u...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Progress in cardiovascular diseases     Volume:  54     ISSN:  1873-1740     ISO Abbreviation:  Prog Cardiovasc Dis     Publication Date:    2012 May-Jun
Date Detail:
Created Date:  2012-06-12     Completed Date:  2012-09-04     Revised Date:  2013-05-02    
Medline Journal Info:
Nlm Unique ID:  0376442     Medline TA:  Prog Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  461-76     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Division of Cardiology, St Luke's-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, 1000 10th Ave, New York City, NY 10019, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiac Resynchronization Therapy / methods*
Cardiac Surgical Procedures / methods*
Cardiomyopathy, Hypertrophic / therapy*,  ultrasonography
Cardiovascular Agents / therapeutic use*
Diagnosis, Differential
Monitoring, Physiologic / methods*
Treatment Outcome
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genetic considerations in hypertrophic cardiomyopathy.
Next Document:  Stress testing in patients with hypertrophic cardiomyopathy.